Two-Year Preclinical Evaluation of Long-Term Absorbable Poly-4-hydroxybutyrate Scaffold for Surgical Correction of Pelvic Organ Prolapse.

Absorbable scaffold Biomechanics Long-term host response Pelvic organ prolapse Poly-4-hydroxybutyrate Vaginal surgery

Journal

International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 06 09 2023
accepted: 14 12 2023
medline: 18 4 2024
pubmed: 2 3 2024
entrez: 2 3 2024
Statut: ppublish

Résumé

Fully absorbable implants may be an alternative to permanent meshes in the correction pf pelvic organ prolapse (POP) as they may reduce adverse events by promoting tissue regeneration and collagen metabolism. This study was aimed at evaluating the long-term host and biomechanical response to a fully absorbable poly-4-hydroxybutyrate (P4HB) scaffold in comparison with polypropylene (PP) mesh. Poly-4-hydroxybutyrate scaffold (n = 16) and PP mesh (n = 16) were surgically implanted in the posterior vaginal wall of parous female Dohne Merino sheep. Vaginal explants were evaluated in terms of gross necropsy, host response (immune response, collagen deposition, tissue regeneration), biomechanics, and degradation of P4HB at 12 and 24 months post-implantation. Gross necropsy revealed no infection or fluid collection using P4HB or PP. At 12 months, exposures were observed with both P4HB (3 out of 8) and PP (4 out of 8), whereas at 24 months, exposures were observed only with PP (4 out of 8). The tensile stiffness of the P4HB explants was maintained over time despite complete absorption of P4HB. The collagen amount of the vaginal tissue after P4HB implantation increased over time and was significantly higher than PP at 24 months. P4HB scaffolds exhibited significantly lower myofibroblast differentiation than PP meshes at 24 months. The P4HB scaffold allowed for gradual load transfer to the vaginal wall and resulted in mechanically self-sufficient tissue. P4HB scaffold had a more favorable host response than PP mesh, with higher collagen content, lower myofibroblastic differentiation, and no exposures at 24 months. P4HB scaffolds have potential as an alternative to permanent implants in treating POP.

Identifiants

pubmed: 38430238
doi: 10.1007/s00192-023-05720-0
pii: 10.1007/s00192-023-05720-0
pmc: PMC11024044
doi:

Substances chimiques

Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

713-722

Informations de copyright

© 2024. The Author(s).

Références

Gynecol Obstet Invest. 2017;82(6):582-591
pubmed: 28125816
Eur Urol Focus. 2020 Jan 15;6(1):190-198
pubmed: 30049658
J Pathol. 2013 Jan;229(2):298-309
pubmed: 22996908
Int Urogynecol J. 2010 Sep;21(9):1151-6
pubmed: 20424823
Front Surg. 2023 Apr 12;10:1157661
pubmed: 37123542
Mater Today Bio. 2022 Apr 19;15:100268
pubmed: 35517580
Int Urogynecol J. 2016 Oct;27(10):1547-55
pubmed: 26992722
Int J Surg. 2020 Nov;83:31-36
pubmed: 32931978
Trends Cell Biol. 2005 Nov;15(11):599-607
pubmed: 16202600
Am J Pathol. 1995 Jan;146(1):56-66
pubmed: 7856739
Microsurgery. 2020 May;40(4):434-439
pubmed: 31815314
Int Urogynecol J. 2011 Jul;22(7):789-98
pubmed: 21424785
Acta Biomater. 2016 Jul 15;39:114-123
pubmed: 27163402
Obstet Gynecol Int. 2012;2012:376251
pubmed: 22291710
Ann Surg. 2017 Jul;266(1):185-188
pubmed: 28594679
Am J Obstet Gynecol. 2001 Dec;185(6):1299-304; discussion 1304-6
pubmed: 11744900
BJOG. 2022 Jun;129(7):1039-1049
pubmed: 34865300
Am J Obstet Gynecol. 2001 Jun;184(7):1357-62; discussion 1362-4
pubmed: 11408853
Acta Biomater. 2019 Oct 1;97:162-176
pubmed: 31386931
Am J Obstet Gynecol. 2015 Apr;212(4):474.e1-8
pubmed: 25446700
Biomolecules. 2022 Jan 06;12(1):
pubmed: 35053242
Mol Hum Reprod. 2008 Feb;14(2):127-35
pubmed: 18184756
Semin Immunol. 2008 Apr;20(2):86-100
pubmed: 18162407
Int J Nanomedicine. 2015 Apr 24;10:3193-201
pubmed: 25995629
Int Urogynecol J. 2011 Feb;22(2):191-6
pubmed: 20838988
Expert Rev Obstet Gynecol. 2012 May 1;7(3):249-260
pubmed: 22707980
Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111702
pubmed: 33545861
BJOG. 2013 Jan;120(2):244-250
pubmed: 23240803
Curr Opin Obstet Gynecol. 2002 Oct;14(5):527-35
pubmed: 12401983
Neurourol Urodyn. 2021 Jun;40(5):1107-1119
pubmed: 33951222
J Sex Med. 2011 Apr;8(4):1239-45
pubmed: 21235724
Oncotarget. 2018 Apr 3;9(25):17937-17950
pubmed: 29707159
BJOG. 2013 Jan;120(2):224-232
pubmed: 23240801
Hernia. 2012 Apr;16(2):191-7
pubmed: 21972049

Auteurs

Zeliha Guler (Z)

Department of Obstetrics and Gynaecology, Amsterdam UMC - location AMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. zeliha.guler@amsterdamumc.nl.
Amsterdam Reproduction and Development, Amsterdam, The Netherlands. zeliha.guler@amsterdamumc.nl.

Lisa Ann Kaestner (LA)

Department of Urology, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.

Eva Vodegel (E)

Department of Obstetrics and Gynaecology, Amsterdam UMC - location AMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Amsterdam Reproduction and Development, Amsterdam, The Netherlands.

Lamees Ras (L)

Department of Obstetrics and Gynecology, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.

Stephen Jeffrey (S)

Department of Obstetrics and Gynecology, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.

Jan Paul Roovers (JP)

Department of Obstetrics and Gynaecology, Amsterdam UMC - location AMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Amsterdam Reproduction and Development, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH